Journal

Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 1535-5667
Titre abrégé: J Nucl Med
Pays: United States
ID NLM: 0217410

Informations de publication

Date de publication:
11 2019
Historique:
received: 27 10 2018
accepted: 04 03 2019
pubmed: 17 3 2019
medline: 31 3 2020
entrez: 17 3 2019
Statut: ppublish

Résumé

There is an unmet need for predictive biomarkers of the clinical benefit of antiangiogenic drugs. The aim of the present study was to prospectively evaluate the value of

Identifiants

pubmed: 30877175
pii: jnumed.118.222604
doi: 10.2967/jnumed.118.222604
pmc: PMC6836863
doi:

Substances chimiques

Fluorodeoxyglucose F18 0Z5B2CJX4D
Bevacizumab 2S9ZZM9Q9V

Types de publication

Clinical Trial, Phase II Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1560-1568

Informations de copyright

© 2019 by the Society of Nuclear Medicine and Molecular Imaging.

Références

Eur J Nucl Med Mol Imaging. 2007 Oct;34(10):1583-93
pubmed: 17503039
Acta Oncol. 2010 Oct;49(7):956-63
pubmed: 20586658
Dis Colon Rectum. 2005 Apr;48(4):722-8
pubmed: 15747073
Oncotarget. 2017 Jan 31;8(5):8143-8153
pubmed: 28042958
J Nucl Med. 2009 May;50 Suppl 1:43S-54S
pubmed: 19403879
J Clin Oncol. 2008 Jan 10;26(2):183-9
pubmed: 18182660
J Clin Oncol. 2014 May 20;32(15):1554-62
pubmed: 24752056
Lancet Oncol. 2015 Feb;16(2):200-7
pubmed: 25589192
J Clin Oncol. 2004 May 15;22(10):1785-96
pubmed: 15067027
Eur J Nucl Med Mol Imaging. 2015 Apr;42(5):657-66
pubmed: 25687534
J Clin Oncol. 2013 Mar 20;31(9):1219-30
pubmed: 23401453
AJR Am J Roentgenol. 2015 Jun;204(6):1261-8
pubmed: 26001237
J Nucl Med. 2013 Dec;54(12):2062-9
pubmed: 24136935
Eur J Nucl Med Mol Imaging. 2012 Dec;39(12):1848-57
pubmed: 23053320
Int J Biochem Cell Biol. 2015 Aug;65:192-6
pubmed: 26055517
Am J Clin Oncol. 2012 Aug;35(4):340-4
pubmed: 21422901
J Am Coll Surg. 2008 Jul;207(1):7-12
pubmed: 18589355
Eur J Surg Oncol. 2014 Oct;40(10):1186-94
pubmed: 25060221
Clin Positron Imaging. 1999 May;2(3):159-171
pubmed: 14516540
Cancer. 1994 Jun 1;73(11):2680-6
pubmed: 8194005
Lancet Oncol. 2015 Jan;16(1):e13-22
pubmed: 25638548
Oncotarget. 2015 Oct 6;6(30):30394-407
pubmed: 26320185
Eur J Nucl Med Mol Imaging. 2015 Feb;42(2):328-54
pubmed: 25452219

Auteurs

Antonio Avallone (A)

Experimental Clinical Abdominal Oncology, IRCCS Istituto Nazionale Tumori "Fondazione Giovanni Pascale," Naples, Italy a.avallone@istitutotumori.na.it.

Luigi Aloj (L)

Nuclear Medicine, IRCCS Istituto Nazionale Tumori "Fondazione Giovanni Pascale," Naples, Italy.

Biagio Pecori (B)

Radiotherapy, IRCCS Istituto Nazionale Tumori "Fondazione Giovanni Pascale," Naples, Italy.

Corradina Caracò (C)

Nuclear Medicine, IRCCS Istituto Nazionale Tumori "Fondazione Giovanni Pascale," Naples, Italy.

Alfonso De Stefano (A)

Experimental Clinical Abdominal Oncology, IRCCS Istituto Nazionale Tumori "Fondazione Giovanni Pascale," Naples, Italy.

Fabiana Tatangelo (F)

Pathology, IRCCS Istituto Nazionale Tumori "Fondazione Giovanni Pascale," Naples, Italy.

Lucrezia Silvestro (L)

Experimental Clinical Abdominal Oncology, IRCCS Istituto Nazionale Tumori "Fondazione Giovanni Pascale," Naples, Italy.

Vincenza Granata (V)

Radiology, IRCCS Istituto Nazionale Tumori "Fondazione Giovanni Pascale," Naples, Italy.

Francesco Bianco (F)

Colorectal Oncological Surgery, IRCCS Istituto Nazionale Tumori "Fondazione Giovanni Pascale," Naples, Italy; and.

Carmela Romano (C)

Experimental Clinical Abdominal Oncology, IRCCS Istituto Nazionale Tumori "Fondazione Giovanni Pascale," Naples, Italy.

Francesca Di Gennaro (F)

Nuclear Medicine, IRCCS Istituto Nazionale Tumori "Fondazione Giovanni Pascale," Naples, Italy.

Alfredo Budillon (A)

Experimental Pharmacology, IRCCS Istituto Nazionale Tumori "Fondazione Giovanni Pascale," Naples, Italy.

Antonella Petrillo (A)

Radiology, IRCCS Istituto Nazionale Tumori "Fondazione Giovanni Pascale," Naples, Italy.

Paolo Muto (P)

Radiotherapy, IRCCS Istituto Nazionale Tumori "Fondazione Giovanni Pascale," Naples, Italy.

Gerardo Botti (G)

Pathology, IRCCS Istituto Nazionale Tumori "Fondazione Giovanni Pascale," Naples, Italy.

Paolo Delrio (P)

Colorectal Oncological Surgery, IRCCS Istituto Nazionale Tumori "Fondazione Giovanni Pascale," Naples, Italy; and.

Secondo Lastoria (S)

Nuclear Medicine, IRCCS Istituto Nazionale Tumori "Fondazione Giovanni Pascale," Naples, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH